Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login
 Back To Article

  Reader Comments

Year : 2017 | Volume:  13 | Issue Number:  3

ORIGINAL ARTICLE

Docetaxel plus cisplatin plus fluorouracil versus carboplatin plus fluorouracil-cetuximab in first-line setting in patients with recurrent or metastatic head and neck squamous cell cancer who did not previously receive neoadjuvant or adjuvant chemotherapy, which is standard?

Mutlu Hasan, Salim Derya Kıvrak, Gündüz Şeyda, Eryılmaz Melek Karakurt, Musri Fatma Yalçın, Coşkun Hasan Şenol

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks